Mannkind Corporation
Symbol: MNKD (NASDAQ)
5.30
▼ (-0.66%) -0.035
Company Description:
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Key Stats
- Today's Open: $5.31
- Today's High: $5.355
- Today's Low: $5.266
- Today's Volume: 296.88K
- Yesterday Close: $5.33
- Yesterday High: $5.43
- Yesterday Low: $5.295
- Yesterday Volume: 3.60M
- Last Min Volume: 923
- Last Min High: $5.295
- Last Min Low: $5.295
- Last Min VWAP: $5.295
Company Profile
- Name: Mannkind Corporation
- Website: https://www.mannkindcorp.com
- Listed Date: 2004-07-28
- Location: DANBURY, CT
- Market Status: Active
- CIK Number: 0000899460
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.64B
- Round Lot: 100
- Outstanding Shares: 306.83M
- Asset Type: CS
RECENT FILINGS FOR MNKD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-24 | SC TO-T/A | View |
| 2025-09-22 | SC TO-T/A | View |
| 2025-09-17 | 4 | View |
| 2025-09-16 | 144 | View |
| 2025-09-08 | SC TO-T | View |
| 2025-08-27 | 8-K | View |
| 2025-08-25 | SC TO-C | View |
| 2025-08-25 | SC TO-C | View |
| 2025-08-25 | SC TO-C | View |
| 2025-08-25 | 8-K | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-24 | UPLOAD | View |
| 2025-07-18 | CORRESP | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
Latest News on MNKD